share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Chaguturu Sreekanth K

CVS Health | 4: Statement of changes in beneficial ownership of securities

西維斯健康 | 4：持股變動聲明
SEC announcement ·  04/04 05:06
牛牛AI助理已提取核心訊息
On April 1, 2024, CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a series of transactions involving the company's common stock. Initially, Chaguturu acquired 6,913 shares of restricted common stock at a price of $79.56 per share. Subsequently, he disposed of 2,298 shares at the same price, which were used to cover the exercise price or tax liability associated with the securities. After these transactions, Chaguturu Sreekanth K's direct holdings in CVS Health totaled 23,666 shares. The total market value of the disposed shares amounted to $182,828.88.
On April 1, 2024, CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a series of transactions involving the company's common stock. Initially, Chaguturu acquired 6,913 shares of restricted common stock at a price of $79.56 per share. Subsequently, he disposed of 2,298 shares at the same price, which were used to cover the exercise price or tax liability associated with the securities. After these transactions, Chaguturu Sreekanth K's direct holdings in CVS Health totaled 23,666 shares. The total market value of the disposed shares amounted to $182,828.88.
2024年4月1日，CVS Health執行副總裁兼首席醫療官Chaguturu Sreekanth K完成了一系列涉及公司普通股的交易。最初，查古圖魯以每股79.56美元的價格收購了6,913股限制性普通股。隨後，他以相同的價格出售了2,298股股票，用於支付與證券相關的行使價或納稅義務。交易完成後，Chaguturu Sreekanth K在CVS Health的直接持股總額爲23,666股。已處置股份的總市值爲182,828.88美元。
2024年4月1日，CVS Health執行副總裁兼首席醫療官Chaguturu Sreekanth K完成了一系列涉及公司普通股的交易。最初，查古圖魯以每股79.56美元的價格收購了6,913股限制性普通股。隨後，他以相同的價格出售了2,298股股票，用於支付與證券相關的行使價或納稅義務。交易完成後，Chaguturu Sreekanth K在CVS Health的直接持股總額爲23,666股。已處置股份的總市值爲182,828.88美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。